150 related articles for article (PubMed ID: 22192967)
1. Effects of intranasal salmeterol and fluticasone given alone and in combination in persistent allergic rhinitis.
Lipworth BJ; Short P; Burns P; Nair A
Ann Allergy Asthma Immunol; 2012 Jan; 108(1):54-59. PubMed ID: 22192967
[TBL] [Abstract][Full Text] [Related]
2. Effects of intranasal fluticasone and salmeterol on allergen-induced nasal responses.
Parameswaran K; Fanat A; O'Byrne PM
Allergy; 2006 Jun; 61(6):731-6. PubMed ID: 16677243
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of salmeterol and fluticasone propionate alone and in combination on airway blood flow in patients with asthma.
Mendes ES; Rebolledo P; Wanner A
Chest; 2012 May; 141(5):1184-1189. PubMed ID: 21980058
[TBL] [Abstract][Full Text] [Related]
4. Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life.
Edin HM; Andersen LB; Schoaf L; Scott-Wilson CA; Ho SY; Ortega HG
Ann Allergy Asthma Immunol; 2009 Apr; 102(4):323-7. PubMed ID: 19441604
[TBL] [Abstract][Full Text] [Related]
5. Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis.
Katial RK; Oppenheimer JJ; Ostrom NK; Mosnaim GS; Yancey SW; Waitkus-Edwards KR; Prillaman BA; Ortega HG
Allergy Asthma Proc; 2010; 31(1):68-75. PubMed ID: 20167147
[TBL] [Abstract][Full Text] [Related]
6. Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study.
Meltzer EO; Stahlman JE; Leflein J; Meltzer S; Lim J; Dalal AA; Prillaman BA; Philpot EE
Clin Ther; 2008 Feb; 30(2):271-9. PubMed ID: 18343265
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effect of low-dose ciclesonide and fixed-dose fluticasone propionate and salmeterol combination on long-term asthma control.
Postma DS; O'Byrne PM; Pedersen S
Chest; 2011 Feb; 139(2):311-318. PubMed ID: 21088114
[TBL] [Abstract][Full Text] [Related]
8. Intranasal ciclesonide coadministration with inhaled fluticasone propionate-salmeterol does not suppress cortisol in allergic rhinitis patients.
Kim K; Quesada J; Szmaydy-Rikken N; Darken P; Shah T
J Asthma; 2007 Sep; 44(7):515-20. PubMed ID: 17885853
[TBL] [Abstract][Full Text] [Related]
9. A proof-of-concept study to assess the putative dose response to topical corticosteroid in persistent allergic rhinitis using adenosine monophosphate challenge.
Barnes ML; Menzies D; Nair AR; Hopkinson PJ; Lipworth BJ
Clin Exp Allergy; 2007 May; 37(5):696-703. PubMed ID: 17456217
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
[TBL] [Abstract][Full Text] [Related]
11. Addition of a 5-lipoxygenase-activating protein inhibitor to an inhaled corticosteroid (ICS) or an ICS/long-acting beta-2-agonist combination in subjects with asthma.
Snowise NG; Clements D; Ho SY; Follows RM
Curr Med Res Opin; 2013 Dec; 29(12):1663-74. PubMed ID: 24010736
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
13. Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease.
Vestbo J; Pauwels R; Anderson JA; Jones P; Calverley P;
Thorax; 2005 Apr; 60(4):301-4. PubMed ID: 15790985
[TBL] [Abstract][Full Text] [Related]
14. Fluticasone/Salmeterol combination confers benefits in people with asthma who smoke.
Clearie KL; McKinlay L; Williamson PA; Lipworth BJ
Chest; 2012 Feb; 141(2):330-338. PubMed ID: 21636667
[TBL] [Abstract][Full Text] [Related]
15. Effects of intranasal corticosteroid on nasal adenosine monophosphate challenge in persistent allergic rhinitis.
Barnes ML; Biallosterski BT; Fujihara S; Gray RD; Fardon TC; Lipworth BJ
Allergy; 2006 Nov; 61(11):1319-25. PubMed ID: 17002709
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients.
Dransfield MT; Feldman G; Korenblat P; LaForce CF; Locantore N; Pistolesi M; Watkins ML; Crim C; Martinez FJ
Respir Med; 2014 Aug; 108(8):1171-9. PubMed ID: 24998880
[TBL] [Abstract][Full Text] [Related]
17. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
[TBL] [Abstract][Full Text] [Related]
18. Addition of fexofenadine to inhaled corticosteroid therapy to reduce inflammatory biomarkers in atopic asthma.
Fardon TC; Lee DK; Hodge MR; Lipworth BJ
Ann Allergy Asthma Immunol; 2005 Sep; 95(3):259-65. PubMed ID: 16200817
[TBL] [Abstract][Full Text] [Related]
19. Nasal cytology in patients with allergic rhinitis: effects of intranasal fluticasone propionate.
Meltzer EO; Orgel HA; Rogenes PR; Field EA
J Allergy Clin Immunol; 1994 Oct; 94(4):708-15. PubMed ID: 7930304
[TBL] [Abstract][Full Text] [Related]
20. Effects of fluticasone plus salmeterol versus twice the dose of fluticasone in asthmatic patients.
Currie GP; Bates CE; Lee DK; Jackson CM; Lipworth BJ
Eur J Clin Pharmacol; 2003 May; 59(1):11-5. PubMed ID: 12743669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
